EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Ligustilide, A Novel Senolytic Compound Isolated from the Roots of Angelica Acutiloba

Kento Takaya iD, Kazuo Kishi

Advanced Biology · 2024

DOI: 10.1002/adbi.202300434 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Biology, 2024. Verfasst von Kento Takaya und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic and Reconstructive Surgery, Keio University School of Medicine, Shinjuku, Tokyo, 160-8582, Japan. Hauptthemen laut MEDLINE: Angelica, 4-Butyrolactone, Fibroblasts, Cellular Senescence. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Senescent cells accumulate with age and contribute to age‐related diseases and organ dysfunctions. Early evidence suggests that removal of senescent cells using senolytic drugs improves the aging phenotype in mice and may improve the health of individuals with chronic diseases. Signs of skin aging, including wrinkles, and sagging, occur largely due to the accumulation of senescent fibroblasts within the dermis; However, there is currently no skin treatment that eliminates senescent cells. In this study, human fibroblasts subjected to replicative aging and ionizing radiation exposure are used to screen plant extracts for potential senescent cell‐destructive and/or senescent cell‐forming activities. Angelica acutiloba —a traditional Chinese herbal medicine—selectively kills senescent cells without affecting the proliferating cells. Among the major components of this herb, ligustilide shows promising senescent cell‐destructive properties, and selectively eliminates senescent cells by inducing an apoptosis. Moreover, ligustilide markedly inhibits senescence‐associated secretory phenotypes. Administration of ligustilide to mouse skin eliminates senescent cells and increases dermal collagen density and subcutaneous adipose tissue content; it selectively promotes death of senescent cells without affecting non‐senescent cells. These results provide evidence that a natural compound—ligustilide—may exhibit therapeutic effects on the skin aging phenotype by specifically inducing apoptosis in senescent cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angelica4-ButyrolactoneFibroblastsCellular SenescencePlant RootsAnimalsMiceHumansApoptosisSkin AgingSenotherapeuticsPlant Extracts

Stichwörter der Autor:innen

fibroblastsligustilidesenolysisskin aging

Substanzen

ligustilide4-ButyrolactoneSenotherapeuticsPlant Extracts

Autor:innen und Institutionen

  • Department of Plastic and Reconstructive Surgery, Keio University School of Medicine, Shinjuku, Tokyo, 160-8582, Japan.

ORCID-Profile: Kento Takaya

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Takaya, K., & Kishi, K. (2024). Ligustilide, A Novel Senolytic Compound Isolated from the Roots of Angelica Acutiloba. Advanced Biology. https://doi.org/10.1002/adbi.202300434

Vancouver

Takaya K, Kishi K. Ligustilide, A Novel Senolytic Compound Isolated from the Roots of Angelica Acutiloba. Advanced Biology. 2024. doi:10.1002/adbi.202300434

BibTeX
@article{Takaya2024,
  author = {Takaya, Kento and Kishi, Kazuo},
  title = {Ligustilide, A Novel Senolytic Compound Isolated from the Roots of Angelica Acutiloba},
  journal = {Advanced Biology},
  year = {2024},
  doi = {10.1002/adbi.202300434}
}
Kostenlos starten →